Cryo-EM structures reveal how the first-in-class antifungal drug manogepix inhibits fungal GWT1, a key enzyme for GPI-anchored protein synthesis. The study uncovers manogepix’s competitive binding mechanism and explains drug resistance, offering insights for more effective antifungal therapies.
- Xinli Dai
- Xuanzhong Liu
- Xiang Wang
